 | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Fabian Kiessling (born 16 August 1972) is a German radiologist, university lecturer, and author as well as a scientist in the field of molecular imaging.
Fabian Kiessling was born Mannheim and graduated high school in 1992 in Heidelberg and studied medicine at Heidelberg University. After his elective period at the district hospital in Schwetzingen, he completed his studies with the second state examination and was awarded his doctorate in 2001 in Internal Medicine. [1]
From 2001 he worked in the Dept. of Oncological Diagnostics and Therapy at the German Cancer Research Center (DKFZ) in Heidelberg and stayed there as an intern until 2002.
In 2003 he moved to the Dept. of Oncology at the Thorax Clinic Heidelberg and in parallel became head of the Molecular Diagnostics group in the Dept. of Medical Physics in Radiology at the DKFZ. In 2006, he became the Junior Group Leader for 'Molecular Imaging' at the DKFZ and habilitated in Experimental Radiology at the Heidelberg University.
2007 he completed his education as a medical specialist in diagnostic radiology.
In March 2008 he was appointed as full professor and director of the Institute for Experimental Molecular Imaging (ExMI) at RWTH Aachen (Rheinisch-Westfälische Technische Hochschule Aachen). He is also one of the directors of the RWTH Helmholtz Institute for Biomedical Engineering.
The research of Fabian Kiessling focusses on the development of new imaging methods and probes, with a particular focus on oncology and diseases that go along with angiogenesis and vascular remodeling. He worked on the imaging technique volumetric area detector computed tomography [2] and published the new ultrasound technique Motion Model Ultrasound Localization Microscopy together with his colleague Georg Schmitz. The ultrasound technique was preclinically tested and used in a first clinical application. [3] Both methods allow non-invasive imaging of hair-thin blood vessels in tumors and other tissues. In his translational research, imaging-guided therapy plays an important role including the investigation of biological barriers for drug delivery and the development of strategies to overcome these barriers by the use of nanomedicines, drug delivery systems, and other therapeutics.
{{cite book}}: CS1 maint: others (link){{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link){{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link){{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
A biopsy is a medical test commonly performed by a surgeon, an interventional radiologist, or an interventional cardiologist. The process involves the extraction of sample cells or tissues for examination to determine the presence or extent of a disease. The tissue is then fixed, dehydrated, embedded, sectioned, stained and mounted before it is generally examined under a microscope by a pathologist; it may also be analyzed chemically. When an entire lump or suspicious area is removed, the procedure is called an excisional biopsy. An incisional biopsy or core biopsy samples a portion of the abnormal tissue without attempting to remove the entire lesion or tumor. When a sample of tissue or fluid is removed with a needle in such a way that cells are removed without preserving the histological architecture of the tissue cells, the procedure is called a needle aspiration biopsy. Biopsies are most commonly performed for insight into possible cancerous or inflammatory conditions.
The Gottfried Wilhelm Leibniz Prize, or Leibniz Prize, is awarded by the German Research Foundation to "exceptional scientists and academics for their outstanding achievements in the field of research". Since 1986, up to ten prizes have been awarded annually to individuals or research groups working at a research institution in Germany or at a German research institution abroad. It is considered the most important research award in Germany.
University Hospital Heidelberg is a university hospital in Heidelberg, Germany and is with 1,991 beds one of the largest medical centers in the country. It is closely linked to Heidelberg University Medical School which was founded in 1388 and is thus the oldest within the Federal Republic of Germany.
Ralph Weissleder is an American clinician scientist.
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging, positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.
Paul Workman is a British scientist noted for his work on the discovery and development of pharmaceutical agents in the field of oncology. He was President and CEO of The Institute of Cancer Research in London from 2014 to 2021.
Martin Zenke is a German biochemist, cell biologist, professor for cell biology and scientist, who is conducting research on stem cells and biomedical engineering.
Minesh Prafulchandra Mehta is an American radiation oncologist and physician-scientist of Indian origin and Ugandan birth. He is currently deputy director and chief of radiation oncology at Miami Cancer Institute at Baptist Health South Florida.
Alexander R. Margulis was a Serbian American physician who was a professor of radiology at Weill Cornell Medical College, Cornell University. He was formerly the Associate Chancellor and Chairman of Radiology at University of California, San Francisco. Over 8 of his papers have each been cited over 100 times.
Sanjiv Sam Gambhir was an American physician–scientist. He was the Virginia and D.K. Ludwig Professor in Cancer Research, Chairman of the Department of Radiology at Stanford University School of Medicine, and a professor by courtesy in the departments of Bioengineering and Materials Science and Engineering at Stanford University. Additionally, he served as the Director of the Molecular Imaging Program at Stanford (MIPS), Canary Center at Stanford for Cancer Early Detection and the Precision Health and Integrated Diagnostics Center (PHIND). He authored 680 publications and had over 40 patents pending or granted. His work was featured on the cover of over 25 journals including the Nature Series, Science, and Science Translational Medicine. He was on the editorial board of several journals including Nano Letters, Nature Clinical Practice Oncology, and Science Translational Medicine. He was founder/co-founder of several biotechnology companies and also served on the scientific advisory board of multiple companies. He mentored over 150 post-doctoral fellows and graduate students from over a dozen disciplines. He was known for his work in molecular imaging of living subjects and early cancer detection.
Ferenc Andras Jolesz was a Hungarian-American physician and scientist best known for his research on image guided therapy, the process by which information derived from diagnostic imaging is used to improve the localization and targeting of diseased tissue to monitor and control treatment during surgical and interventional procedures. He pioneered the field of Magnetic Resonance Imaging-guided interventions and introduced of a variety of new medical procedures based on novel combinations of imaging and therapy delivery.
Sandip Basu is an Indian physician of Nuclear Medicine and the Head, Nuclear Medicine Academic Program at the Radiation Medicine Centre. He is also the Dean-Academic (Health-Sciences), BARC at Homi Bhabha National Institute and is known for his services and research in Nuclear Medicine, particularly on Positron emission tomography diagnostics and Targeted Radionuclide Therapy in Cancer. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Nuclear Medicine in 2012.
Bernd Pichler is a German biomedical engineer and expert in preclinical and molecular imaging as well as in imaging technology. He is Chair of the Department of Preclinical Imaging and Radiopharmacy as well as Director of the Werner Siemens Imaging Center at the University of Tübingen, Germany. He is the dean of the Faculty of Medicine of the University of Tübingen and member of the University Hospital Executive Board of Directors.
Ivo Meinhold-Heerlein is a German gynaecologist and obstetrician, honorary professor, university professor and deputy director of the Department of Gynaecology and Obstetrics at the University Hospital RWTH Aachen University. He is known for his work in the fields of molecular characterization of ovarian cancer.
Jonathan S. Lewin is an American neuroradiologist specializing in medical imaging research with an emphasis on the investigation, development, and translation of new magnetic resonance imaging (MRI) techniques. He is the former executive vice president for health affairs (EVPHA) and executive director of the Woodruff Health Sciences Center for Emory University, and former President, CEO, and chairman of the board of Emory Healthcare. He currently serves as professor of radiology, biomedical engineering, and neurosurgery in the Emory School of Medicine and as professor of health policy and management in the Rollins School of Public Health.
Jason S. Lewis is a British radiochemist whose work relates to oncologic therapy and diagnosis. His research focus is a molecular imaging-based program focused on radiopharmaceutical development as well as the study of multimodality small- and biomolecule-based agents and their clinical translation. He has worked on the development of small molecules as well as radiolabeled peptides and antibodies probing the overexpression of receptors and antigens on tumors.
Luis Marti-Bonmati is a Spanish professor and researcher. He is the director of the Clinical Area of Medical Imaging Department at La Fe Polytechnic and University Hospital, and Head of Radiology Department at QuironSalud Hospital, Valencia, Spain. Marti-Bonmati is the founder of QUIBIM S.L., and is the Director of its Scientific Advisory Board. He is a member of the Spanish National Royal Academy of Medicine. He is also the director of the Biomedical Imaging Research Group (GIBI230) at La Fe Health Research Institute. The group is now included in the Imaging La Fe node at Distributed Network for Biomedical Imaging (ReDIB) Unique Scientific and Technical Infrastructures (ICTS), Valencia, Spain.
Jamshed Bomanji is a full professor, clinical lead, and head of the Institute of Nuclear medicine department at the University College Hospital (UCLH) NHS foundation trust based in London, UK.
Vicky Goh is a professor, chair of clinical cancer imaging, and head of cancer imaging department at the King's College London, England, United Kingdom. She joined King's College London in 2011. She is also a consultant radiologist at Guy's and St Thomas' Hospital in London.
Damian E. Dupuy, M.D., F.A.C.R. is an adjunct professor of Diagnostic Imaging at Brown University's Warren Alpert Medical School and Director of Ablation services at Cape Cod Hospital. He is also a Member of Cape Cod preferred Physicians.
| International | |
|---|---|
| National | |
| Academics | |
| People | |
| Other | |
